Advertisement
Findings from a clinical trial and secondary analysis demonstrate clinical utility, safety
Relapses are frequent even with long periods of remission
A unique approach provides long-lasting results with minimal impact on the disease state
New innovations improve treatment of this rare disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
What to look for and when to use immunosuppressive medications
Careful planning and counseling prior to conception provide best potential for a safe outcome
Toward an evidence-based approach
Multinational study builds on promising pilot results
Use a low threshold for screening GPA/MPA/EGPA patients
Persistently active vasculitis may play a role
Advertisement
Advertisement